Volume 3, Number 2 (March/April 2005)

Bench to Bedside

101

  

A Multidisciplinary Approach to Gastrointestinal Bleeding in Cancer Patients
John J. Imbesi, MD, and Robert C. Kurtz, MD

Gastroenterology and Nutrition Service, Memorial Sloan-Kettering Cancer Center, and Joan and Sanford I. Weill Medical College, Cornell University, New York, New York

With a peer viewpoint by Lawrence R. Coia, MD, Department of Radiation Oncology, Community Medical Center, Toms River, New Jersey

abstract full text 230 kb

117

  

Managing Malignancy-Associated Hyperuricemia With Rasburicase
Bruce D. Cheson, MD, and Bonni S. Dutcher, PhD

Department of Hematology and Oncology, Georgetown University, Lombardi Comprehensive Cancer Center, Washington, DC, and Sanofi-Aventis Corporation, Bridgewater, New Jersey

With a peer viewpoint by Julia M. Cruz, MD, and Allen R. Chauvenet, MD, Departments of Medical and Pediatric Hematology/Oncology, Wake Forest University School of Medicine, Winston-Salem, North Carolina

abstract full text 148 kb

Original Research

149

  

Patient Preferences in Choosing Chemotherapy Regimens for Advanced Non-Small Cell Lung Cancer
Sarita Dubey, MD, Roger L. Brown, PhD, Sarah L. Esmond, MS, Barbara J. Bowers, PhD,Janet M. Healy, and Joan H. Schiller, MD

University of Wisconsin Comprehensive Cancer Center, Madison; Department of Nursing Research, University of Wisconsin School of Nursing, Madison; Center for the Study of Cultural Diversity in Healthcare, University of Wisconsin Medical School, Madison; Australian Catholic University, Melbourne; and the Alliance for Lung Cancer Advocacy, Support, and Education, Washington, DC

abstract full text 133 kb

Editorial

133

  

Quality of Life Outcomes: Measurement and Intervention
David Cella, PhD

Northwestern University Feinberg School of Medicine, and Director, Center on Outcomes, Research and EducationEvanston Northwestern Healthcare, Evanston, Illinois

full text 58 kb

Quality of Life Outcomes: Measurement and Intervention

139

  

Measuring Quality of Life in Patients With Melanoma: Development of the FACT–Melanoma Subscale
Janice N. Cormier, MD, MPH, Latunya Davidson, MPH, Yan Xing, MD, MS, Kimberly Webster, MA, and David Cella, PhD

Departments of Surgical Oncology and Biomathematics, The University of Texas M. D. Anderson Cancer Center, Houston, and the Center on Outcomes, Research, and Education, Evanston Northwestern Healthcare, Evanston, Illinois

full text 184 kb

Commentary

157

  

Finding Meaning, Balance, and Personal Satisfaction in the Practice of Oncology
Tait D. Shanafelt, MD

Departments of Oncology and Hematology/Oncology, Mayo Clinic, Rochester, Minnesota

full text 143 kb

How We Do It

169

  

Management of Malignant Pleural Effusions and Ascites
Anne M. Covey, MD

Department of Diagnostic Radiology, Memorial Sloan-Kettering Cancer Center, New York, New York

full text 162 kb

How We Say It

97

  

Doctor, I Don’t Want Chemotherapy!
Mark Hoffman, MD, and Tomer T. Levin, MD

Division of Hematology-Oncology, Long Island Jewish Medical Center, Albert Einstein School of Medicine, New Hyde Park, New York

full text 62 kb

Observations

128

  

Clofarabine Gains Accelerated Approval From FDA

full text 30 kb

154

  

Liposomal Doxorubicin Earns Full Approval for Treatment of Ovarian Cancer

full text 33 kb

© 2005 Elsevier Inc. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the publisher.

The opinions expressed herein are those of the authors or advertisers. The authors, editors, and publishers make every effort to ensure that no inaccurate or misleading data, opinion, or statement is published in this journal and that drug names, dosages, and recommendations are accurate. However, readers should confirm all dosage schedules against the manufacturer’s package information data. The Publisher, Editorial Board, and their employees accept no liability whatsoever for the consequences of any inaccurate or misleading data, opinion, or statement.